Travere Therapeutics【TVTX】銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

通貨

20.15

買値

20.00

売値

21.10

出来高

987,265

20.06 日の範囲 21.20

5.12 52 週間の範囲 21.56

時価総額

1.573B

前日終値

20.22

始値

20.11

時刻

21.1

最終取引時間

財務取引量

US$ 20,465,891

VWAP

20.7299

平均取引量 (3 か月)

1,215,764

発行済株式数

78,049,928

配当利回り

PER

-14.78

1 株当たり利益 (EPS)

-1.43

歳入

145.24M

純利益

-111.4M

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. 詳細を表示

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

travere.com

本社

Lewes, Delaware, USA

設立

Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker TVTX. The last closing price for Travere Therapeutics was US$20.22. Over the last year, Travere Therapeutics shares have traded in a share price range of US$ 5.12 to US$ 21.56.

Travere Therapeutics currently has 78,049,928 shares in issue. The market capitalisation of Travere Therapeutics is US$1.58 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -14.78.

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.02	-0.0991571641051	20.17	21.4	19.67	1139325	20.67123294	CS
4	1.29	6.83987274655	18.86	21.56	16.8	1210515	19.34790709	CS
12	1.39	7.40938166311	18.76	21.56	16.588	1215764	18.49360475	CS
26	12.16	152.190237797	7.99	21.56	7.95	1518692	15.83041479	CS
52	11.83	142.1875	8.32	21.56	5.12	1354692	12.19009824	CS
156	-5.85	-22.5	26	30.35	5.12	1227338	15.26026436	CS
260	-5	-19.8807157058	25.15	33.0899	5.12	1085065	16.64327721	CS

TVTX - Frequently Asked Questions (FAQ)

What is the current Travere Therapeutics share price?

The current share price of Travere Therapeutics is US$ 20.15

How many Travere Therapeutics shares are in issue?

Travere Therapeutics has 78,049,928 shares in issue

What is the market cap of Travere Therapeutics?

The market capitalisation of Travere Therapeutics is USD 1.58B

What is the 1 year trading range for Travere Therapeutics share price?

Travere Therapeutics has traded in the range of US$ 5.12 to US$ 21.56 during the past year

What is the PE ratio of Travere Therapeutics?

The price to earnings ratio of Travere Therapeutics is -14.78

What is the cash to sales ratio of Travere Therapeutics?

The cash to sales ratio of Travere Therapeutics is 11.33

What is the reporting currency for Travere Therapeutics?

Travere Therapeutics reports financial results in USD

What is the latest annual turnover for Travere Therapeutics?

The latest annual turnover of Travere Therapeutics is USD 145.24M

What is the latest annual profit for Travere Therapeutics?

The latest annual profit of Travere Therapeutics is USD -111.4M

What is the registered address of Travere Therapeutics?

The registered address for Travere Therapeutics is 16192 COASTAL HWY, LEWES, DELAWARE, 19958

What is the Travere Therapeutics website address?

The website address for Travere Therapeutics is travere.com

Which industry sector does Travere Therapeutics operate in?

Travere Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
CAPTCaptiVision Inc	US$ 1.024 (133.26%)	246M
QNTMQuantum Biopharma Ltd	US$ 6.70 (110.69%)	78.56M
LTRYLottery com Inc	US$ 0.58 (85.90%)	129.21M
CPIXCumberland Pharmaceutical Inc	US$ 3.7801 (77.47%)	18.49M
INKTMiNK Therapeutics Inc	US$ 12.08 (53.69%)	350.86k
OMGAOmega Therapeutics Inc	US$ 0.1473 (-69.25%)	11.71M
VIRXViracta Therapeutics Inc	US$ 0.0352 (-54.76%)	6.33M
CYNCYNGN Inc	US$ 0.0708 (-39.44%)	137.42M
UPCUniverse Pharmaceuticals Inc	US$ 0.2663 (-36.20%)	1.9M
CSAICloudastructure Inc	US$ 12.98 (-31.68%)	57.03k
NVDANVIDIA Corporation	US$ 118.65 (1.71%)	256.77M
CAPTCaptiVision Inc	US$ 1.024 (133.26%)	246M
PLTRPalantir Technologies Inc	US$ 103.83 (23.99%)	230.5M
RGTIRigetti Computing Inc	US$ 13.71 (1.78%)	159.64M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.1518 (-22.11%)	142.77M